News
Half of trials supporting new cancer drug approval in Europe had high risk of bias
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5619 (Published 19 September 2019) Cite this as: BMJ 2019;366:l5619Linked Research
Design characteristics, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA
Article usage
Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.